Sorafenib Dose Ramp-Up in Hepatocellular Carcinoma (HCC)
Public ClinicalTrials.gov record NCT01203787. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Multicenter, Randomized Pilot Study of the Effect of Sorafenib Dosing Schedule on Tolerability and Drug Delivery
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Open-label study to evaluate the safety and tolerability of Sorafenib dose ramp-up (starting at a lower dose and then gradually increasing the dose) versus standard Sorafenib dosing in subjects with unresectable and/or metastatic hepatocellular carcinoma.
Study identification
- NCT ID
- NCT01203787
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 120 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 20 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2010
- Primary completion
- Dec 31, 2013
- Completion
- Feb 28, 2014
- Last update posted
- Mar 4, 2015
2010 – 2014
United States locations
- U.S. sites
- 9
- U.S. states
- 5
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Florida Hepatology | Gainesville | Florida | 32610-0277 | — |
| Mayo Clinic | Jacksonville | Florida | 32224 | — |
| Florida Hospital Transplant Center | Orlando | Florida | 32804 | — |
| Tampa General Hospital | Tampa | Florida | 33606 | — |
| Loyola University Medical Center | Maywood | Illinois | 60153 | — |
| Henry Ford Health System | Detroit | Michigan | 48202 | — |
| Drexel University College of Medicine | Philadelphia | Pennsylvania | 19107 | — |
| University of Texas Health Science Center Houston | Houston | Texas | 77030 | — |
| Brooke Army Medical Center | San Antonio | Texas | 78234 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Hepatocellular Carcinoma trials
Other public records listing Hepatocellular Carcinoma. Sorted by last update posted; newest first. Not a recommendation.
- NCT05394259: A Pilot Study to Assess the Clinical Utility of PYLARIFY PET-CT for Detecting Metastasis in Pancreatic Cancer, Hepatocellular Carcinoma and Breast Cancer Active, not recruiting
- NCT07732686: Analysis of Breath Volatile Organic Compounds Using Mass Spectrometry Not yet recruiting
- NCT06764316: A First-in-human Study to Learn About the Safety of BAY 3547926 and How Well it Works in Participants With Advanced Liver Cancer Recruiting
- NCT07627191: GLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular Cancer Not yet recruiting
- NCT07608458: Scheduled Meditation for Improving Postoperative Outcomes in Patients Undergoing Pancreatectomy Not yet recruiting
- NCT05620771: Therasphere® and Systemic Therapy for Patients With Hepatocellular Carcinoma That is High-risk Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01203787, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 4, 2015 · Synced Sep 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01203787 live on ClinicalTrials.gov.